Nanion Corporate Blog


17.01.2021: Drug Discovery for Ion Channel XXII Satellite Meeting

Drug Discovery for Ion Channel XXII Satellite Meeting

Register Here

[Keynote Speaker]

Dr. Stephen Griffin, Associate Professor, Leeds Institute of Medical Research, School of Medicine, University of Leeds

Presenting: Plugging the holes in antiviral therapy – Drug discovery potential of viroporins

Dr. Julie Klint, Head of Ion Channel section, Molecular Screening; Lundbeck

Presenting: Drug discovery of Kv7.2/7.3 openers - Validation of automated patch clamp multi-parameter readout assay

Dr. David Baez-Nieto, Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT

Biophysical analyses of rare CACNA1I missense variants reveal a molecular phenotype associated with schizophrenia

Professor John Atack, Director, Medicines Discovery Institute, Cardiff University

Presenting: GABAA Receptor Modulators – The Story Continues

Professor Irina Vetter, Institute for Molecular Bioscience & School of Pharmacy, The University of Queensland

Presenting: Neurotoxic venom peptides from the giant Australian stinging tree

Dr. Andrew Jenkins, Ph.D., Director of Graduate Studies, Molecular & Systems Pharmacology Training Program, Associate Professor, Departments of Anesthesiology, Pharmacology & Chemical Biology, Emory University School of Medicine

Presenting: GABA(A) receptors and disease

Back to Overview

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.